Edition:
United States

Prana Biotechnology Ltd (PRAN.OQ)

PRAN.OQ on NASDAQ Stock Exchange Capital Market

2.68USD
23 Feb 2018
Change (% chg)

$-0.01 (-0.37%)
Prev Close
$2.69
Open
$2.72
Day's High
$2.75
Day's Low
$2.68
Volume
1,299
Avg. Vol
11,597
52-wk High
$4.57
52-wk Low
$2.05

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 0.06 -0.044
Dec 0.07 -0.041
FY 2016 Jun '16 0.07 -0.055
Dec 0.08 -0.005
 
*Note: Units in Millions ofAustralian Dollars
**Note: Units in Australian Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Jun-18 1 1.82 1.82 1.82 --
Year Ending Jun-19 1 2.07 2.07 2.07 --
Earnings (per share)
Year Ending Jun-18 1 -0.54 -0.54 -0.54 --
Year Ending Jun-19 1 -0.58 -0.58 -0.58 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 195.87 33.62
P/E High - Last 5 Yrs. -- 285.81 46.17
P/E Low - Last 5 Yrs. -- 93.64 24.19
Beta -0.28 0.81 0.81
Price to Sales (TTM) 233.99 137.83 8.35
Price to Book (MRQ) 0.21 20.52 5.22
Price to Tangible Book (MRQ) 1.31 28.04 6.44
Price to Cash Flow (TTM) -- 128.31 25.88
% Owned Institutions 2.36 11.86 2.30

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.52
Dividend Yield - 5 Year Avg -- 0.20 2.01
Dividend 5 Year Growth Rate -- 1.85 5.23
Payout Ratio(TTM) -- 8.14 41.36

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -8.91 64.95 9.76
Sales (TTM) vs TTM 1 Yr. Ago -7.20 58.16 7.57
Sales - 5 Yr. Growth Rate -6.64 33.63 10.22
EPS (MRQ) vs Qtr. 1 Yr. Ago 20.19 -94.99 16.24
EPS (TTM) vs TTM 1 Yr. Ago -40.96 -- --
EPS - 5 Yr. Growth Rate -- 46.89 11.55
Capital Spending - 5 Yr. Growth Rate 0.85 43.77 14.75

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.65 2.42
Current Ratio (MRQ) 15.88 6.12 3.39
LT Debt to Equity (MRQ) 0.00 16.21 12.39
Total Debt to Equity (MRQ) 0.00 18.27 15.84
Interest Coverage (TTM) -- -156.52 38.46

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 46.30 54.79
Gross Margin - 5 Yr. Avg. -- 55.30 52.59
EBITD Margin (TTM) -7,465.22 -- --
EBITD - 5 Yr. Avg -7,529.32 -230.69 14.70
Operating Margin (TTM) -7,481.33 -487.70 4.10
Operating Margin - 5 Yr. Avg. -7,541.87 -247.29 9.99
Pre-Tax Margin (TTM) -5,696.87 -463.92 4.83
Pre-Tax Margin - 5 Yr. Avg. -4,373.62 -253.91 10.24
Net Profit Margin (TTM) -5,696.87 -445.10 1.55
Net Profit Margin - 5 Yr. Avg. -4,373.62 -257.36 6.54
Effective Tax Rate (TTM) -- 0.46 21.93
Effective Tax Rate - 5 Yr. Avg. -- 17.72 24.14

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 23,863,557 817,554,851
Net Income/Employee (TTM) -- -520,338 95,586,843
Receivable Turnover (TTM) 0.03 13.83 5.44
Inventory Turnover (TTM) -- 2.38 3.52
Asset Turnover (TTM) 0.00 0.39 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -25.56 -1.04 10.73
Return on Assets - 5 Yr. Avg. -28.07 -0.14 12.03
Return on Investment (TTM) -27.40 -0.71 13.63
Return on Investment - 5 Yr. Avg. -30.90 2.18 15.76
Return on Equity (TTM) -27.40 -3.37 15.39
Return on Equity - 5 Yr. Avg. -30.90 -1.91 17.03
  1 Year 3 Year 5 Year
Sales % -7.19 -28.60 -6.64
EPS (TTM) % 2.43 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Prana Biotechnology Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 2.36%
# of Holders: 16
Total Shares Held: 210,341
3 Mo. Net Change: 32,959
# New Positions: 1
# Closed Positions: 3
# Increased Positions: 3
# Reduced Positions: 5
# Net Buyers: -2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.